» Articles » PMID: 17868334

Interstrain Differences in Susceptibility to Non-alcoholic Steatohepatitis

Overview
Specialty Gastroenterology
Date 2007 Sep 18
PMID 17868334
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: The pathophysiological mechanisms leading to the development of non-alcoholic steatohepatitis (NASH) remain unclear. There are differences in the susceptibility to NASH between the different species and sexes. The investigation of the precise mechanism of interstrain differences may provide new means by which the pathophysiological mechanisms of NASH may be understood.

Methods: C57BL/6N and C3H/HeN mice were administered a methionine- and choline-deficient (MCD) diet to establish a dietary model of NASH.

Results: An elevation of the serum alanine aminotransferase and increased infiltration of inflammatory cells were predominant in C57BL/6N mice at 8 weeks. The increase in the steatosis and lipid contents in the liver was greater in C57BL/6N mice than in C3H/HeN mice. The indices of lipid peroxidation demonstrated by F2-isoprostanes or 8-hydroxy-2'-deoxyguanosine also increased in the livers of C57BL/6N mice. Furthermore, Sirius red staining revealed an increase in the degree of fibrosis in C57BL/6N mice given the MCD diet. As a result, the C57BL/6N strain had a higher susceptibility to NASH than the C3H/HeN mice. The carnitine palmitoyltransferase 1A (in beta-oxidation) mRNA and mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase 2 (in ketogenesis) mRNA were downregulated in the C57BL/6N mice in comparison with C3H/HeN mice. There were no differences in the expression of microsomal triglyceride transfer protein or sterol regulatory element binding protein 1 between the C57BL/6N and C3H/HeN mice.

Conclusion: There were interstrain differences in susceptibility to NASH observed in a rodent dietary model. Further evaluations of the precise molecular mechanism of this interstrain difference may provide some indications of the pathophysiological mechanisms of NASH in humans.

Citing Articles

Multi-tissue metabolomics reveal mtDNA- and diet-specific metabolite profiles in a mouse model of cardiometabolic disease.

Shastry A, Wilkinson M, Miller D, Kuriakose M, Veeneman J, Smith M Redox Biol. 2025; 81:103541.

PMID: 39983345 PMC: 11893332. DOI: 10.1016/j.redox.2025.103541.


Experimental Models for Studying Structural and Functional State of the Pathological Liver (Review).

Krylov D, Rodimova S, Karabut M, Kuznetsova D Sovrem Tekhnologii Med. 2024; 15(4):65-82.

PMID: 38434194 PMC: 10902899. DOI: 10.17691/stm2023.15.4.06.


NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models.

Fang J, Celton-Morizur S, Desdouets C Cancers (Basel). 2023; 15(14).

PMID: 37509384 PMC: 10377912. DOI: 10.3390/cancers15143723.


Physiologic and epigenetic effects of nutrients on disease pathways.

Park S, Lee J, Hwang J, Chung M Nutr Res Pract. 2023; 17(1):13-31.

PMID: 36777807 PMC: 9884588. DOI: 10.4162/nrp.2023.17.1.13.


Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research.

Flessa C, Nasiri-Ansari N, Kyrou I, Leca B, Lianou M, Chatzigeorgiou A Int J Mol Sci. 2022; 23(24).

PMID: 36555433 PMC: 9780957. DOI: 10.3390/ijms232415791.